Asseco Poland S.A. (ACP)
Warsaw Stock Exchange · Poland · prices in PLN · close of 27 Oct 2026
Key indicators
| Last close | PLN 250.50 |
|---|---|
| 52-week range | 157.10 – 256.20 |
| Return, 1 month / 3 months | +14.0% / +30.2% |
| Return, 1 year / 3 years | +18.7% / +280.9% |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 35.8% |
| Worst drawdown (1 year) | -32.2% |
| Average daily value traded | 34.78M PLN |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Asseco Poland is a software company based in Poland that develops and supplies information technology systems for businesses and public institutions. Its products and services cover banking and insurance software, enterprise resource planning, and IT solutions for public administration and other sectors. The company serves customers in Poland and across Central and Eastern Europe, and it has expanded internationally through acquisitions of other software firms.
Asseco Poland S.A. trades under the code ACP on the Warsaw Stock Exchange in Poland, with its price quoted in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Asseco Poland S.A. (ACP) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 250.50 on 27 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 38 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.7% and over the last three months it rose 30.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 29.4% | ||
| From 52-week high | -0.2% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 30.2% | ||
| 6-month return | 44.3% | ||
| 12-month return, skipping the last month | 4.1% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.2% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 34.78M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +6.8% |
|---|---|
| 1 month | +14.0% |
| 3 months | +30.2% |
| 6 months | +44.3% |
| 1 year | +18.7% |
| 3 years | +280.9% |
| 5 years | +225.0% |
Signals
| 50-day / 200-day average | 229.81 / 193.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 May 2026 | PLN 13.0500 |
| 23 Jun 2025 | PLN 3.9400 |
| 20 Jun 2024 | PLN 3.6600 |
| 16 Jun 2023 | PLN 3.5000 |
| 9 Jun 2022 | PLN 3.3600 |
| 2 Jun 2021 | PLN 3.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.